Serenol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serenol

Property Description
Active ingredient Swedish Flower Pollen Extract, Royal Jelly, Chromium Picolinate
Form Oral Solids (e.g., Tablets)
Pharmacological class Dietary Supplement / Nutritional Support
General purpose Support for emotional symptoms related to hormonal fluctuations
Origin Botanical and Zoological (derived natural)

What Type of Medicine is Serenol?

Serenol is categorized as a specialized nutritional supplement, distinguishing it from conventional pharmaceuticals. It is a multi-component combination product that falls under the regulatory framework for dietary supplements in the United States, meaning it has not been reviewed by the FDA for safety or efficacy as a drug. This unique proprietary formulation is typically manufactured and marketed in the form of oral solids, such as tablets, for administration via the oral route, offering targeted support specifically for individuals experiencing hormone-related discomforts.


Serenol Composition and Natural Origin

The composition of Serenol is a proprietary blend of active ingredients primarily sourced from botanical and zoological kingdoms. The key components include a purified cytoplasmic extract of Swedish flower pollen, Royal Jelly, and the essential mineral Chromium Picolinate. This blend is clinically recognized for its focus on supporting women's health during times of change, such as perimenopause. Research has examined the utility of key components, noting that certain specialized pollen extracts are associated with supporting the normal regulation of symptoms related to hormonal transitions. The research indicates that these natural components may contribute to easing the discomfort associated with temporary hormonal changes.


What is the General Purpose of Serenol?

The general purpose of Serenol is to provide nutritional support for the body’s ability to manage emotional symptoms related to hormonal fluctuations, such as those that may occur during the menstrual cycle or perimenopause. The components are intended to help reduce feelings of irritability, uneasiness, and temporary mood swings, supporting a general sense of emotional stability. Chromium Picolinate, a well-studied element in the formulation, functions as an insulin cofactor. This fact suggests the mineral helps the body maintain healthy glucose metabolism, a factor often linked to mood regulation. The overall intent of the supplement is to promote internal equilibrium.

What side effects are possible with Serenol?

Possible Side Effects and Safety Information

The safety profile for Serenol is defined by the known risks and warnings associated with its components: Swedish Flower Pollen Extract, Royal Jelly, and Chromium Picolinate, based on government regulatory and professional safety documents. As a multi-component dietary supplement, it does not possess a unified government-approved drug label.

Absolute Safety Constraints and Allergies

The most critical safety warning relates to the presence of Royal Jelly. Individuals with a known allergy to bees or bee products must avoid this supplement. The serious adverse reaction documented is the risk of anaphylaxis, a severe, potentially life-threatening allergic reaction.

Officially Documented Adverse Reactions

Adverse effects are categorized based on regulatory-style data, primarily for Chromium Picolinate:

System-Organ Class (SOC) Adverse Reaction (Associated Component) Frequency Classification
Psychiatric/Nervous System Headache, Insomnia, Mood changes Common
Gastrointestinal Disorders Abdominal pain, Bloody stool Not Specified
Hepatobiliary Disorders Liver problems (e.g., Jaundice) Serious/Rare

Serious Adverse Reactions

Official safety information documents rare but serious risks that require immediate medical attention:

  • Anaphylaxis (due to Royal Jelly).
  • Signs of liver problems (Hepatotoxicity, Jaundice, dark urine) or kidney failure (associated with Chromium Picolinate).
  • Severe neurological issues, including trouble concentrating or coordination problems.

Population-Specific Avoidance

Use is strongly discouraged in individuals with certain pre-existing conditions, as advised in regulatory-style warnings for its components:

  • Pre-existing Conditions: Caution advised for those with liver disease, kidney disease, diabetes, mental illness, or a thyroid disorder.
  • Pregnancy and Lactation: Use should be avoided without medical advice due to a lack of reliable safety information.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose information for this multi-component preparation is based strictly on the documented toxicological profiles and regulatory safety guidance for its active ingredients. Suspected overdose is associated with severe systemic manifestations and requires immediate professional medical intervention.

Documented Manifestations: Manifestations of acute over-ingestion of the chromium component include severe gastrointestinal disturbances such as vomiting and diarrhea, and signs of internal bleeding, specifically the presence of blood in urine or stools or coughing up blood.

Severe Outcomes: The official profile highlights the risk of severe outcomes. This includes anaphylaxis associated with the Royal Jelly component, with signs such as difficult breathing or swelling of the face, lips, or throat. High-dose exposure to the chromium component may lead to potential liver damage and kidney damage.

Required Emergency Actions: Immediate medical attention must be sought upon any suspicion of overdose or the appearance of severe symptoms. Regulatory guidance mandates contacting the Poison Help line for consultation. Management is officially constrained by the fact that no known antidote exists for acute chromium toxicity, requiring the use of symptomatic and supportive treatment.

Therapeutic Uses of Serenol

What Serenol Treats: Main Uses and Benefits

Serenol is relevant in contexts involving symptom fluctuations, offering supportive relief for clusters of symptoms associated with the body's natural hormonal changes during key life phases. The supplement is commonly used to help with groups of symptoms that may become intense, such as irritability, mood swings, uneasiness, temporary bloating, and food cravings, which are often linked to premenstrual or perimenopausal changes.

In situations where patients experience symptom fluctuations in women's health, components like the flower pollen extract have been studied. Such support contributes to improved comfort during these cyclical periods. The primary therapeutic benefit is to ease the overall symptom load and assist with maintaining functional stability when manifestations interfere with daily comfort. As one might describe the experience: “It helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Support for Cyclical Discomfort The supplement may be part of symptomatic management for symptoms related to systemic imbalance, particularly in situations involving recurrent or episodic manifestations for adult women during the menstrual cycle and perimenopause.

Eligibility and Restrictions for Use

Who Can and Cannot Use Serenol? (Official Regulatory Information)

The population eligibility for Serenol, a multi-component dietary supplement, is defined by regulatory warnings associated with its ingredients, Swedish Flower Pollen Extract, Royal Jelly, and Chromium Picolinate.

Contraindications and Restrictions

Serenol is strictly contraindicated for individuals with a known allergy to bees or bee products due to the Royal Jelly content, and for those with a known chromate or leather contact allergy.

Use is not recommended in patients with pre-existing kidney disease or liver disease, or in those with mental illness or specific psychiatric conditions. Use is also restricted for individuals with diabetes or those taking insulin or other antidiabetes medications, requiring careful monitoring.

Age and Reproductive Status

The supplement is generally intended for adult women. Use is not recommended in children and adolescents. Safety has not been reliably established for use during pregnancy or breastfeeding, and the product should not be used in these populations without medical advice. Eligibility is contingent upon the absence of these absolute and conditional restrictions.

What should I know about interactions with other medicines?

Serenol Interactions with other Medicines and Products

Serenol is a multi-component dietary supplement, and its official interaction profile is primarily based on the documented regulatory information for its key component, Chromium Picolinate.

Documented Interaction Domains

The regulatory-based information identifies interactions falling into specific categories:

1. Pharmacodynamic Reinforcement:

Interactions are noted with agents that lower blood sugar. Co-administration of Serenol with Insulin or Oral Hypoglycemic Agents may lead to an additive blood-glucose-lowering effect due to chromium's function as an insulin cofactor. Official guidance requires careful monitoring of glycemic control when these combinations are used.

2. Systemic Exposure Alteration:

Certain Antacids may decrease the body's ability to absorb the chromium component. This reduction in absorption could potentially lower its systemic exposure.

3. Interactions with Diet and Concomitant Products:

A diet high in sugar is officially noted to potentially interfere with the effectiveness of the chromium component. Caution is also warranted regarding concurrent use with certain Vitamins, Herbal Products, and Over-the-Counter Medicines.

4. Population-Specific Considerations:

The clinical significance of interactions may be heightened in populations with underlying conditions such as Renal Dysfunction or Malabsorption Syndromes, which are documented as disease interactions for the chromium component.

Mechanism of Action

Serenol, a purified flower pollen extract, exerts its mechanistic actions primarily within prostatic tissue and associated cellular compartments. Its mechanism involves multitarget modulation of several distinct biochemical and cellular pathways.

First, the extract components function as noncompetitive inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes. This dual inhibition restricts the conversion of arachidonic acid into pro-inflammatory prostaglandins and leukotrienes, resulting in a systemic modulation of eicosanoid synthesis and a reduction of local inflammatory mediators.

Second, the extract's compounds interact with alpha1-adrenergic receptors (specifically alpha1A-subtypes) in the smooth muscle cells of the prostate and bladder neck, functioning as functional antagonists. This interaction modulates sympathetic tone, reducing the calcium-dependent contraction of the detrusor and stromal muscle cells and thereby influencing outflow dynamics.

Finally, intracellularly, the extract modulates the activity of the Nuclear Factor-kappa B (NF-kappaB) pathway, leading to a downstream attenuation of pro-inflammatory gene expression and subsequent synthesis of interleukins and other signaling proteins, which influences cellular proliferation and signaling cascades within the targeted tissue.

Dosage and Administration Information

How to Use Serenol

Serenol is administered according to the official instructions provided on its Supplement Facts label, a required document for products classified as a dietary supplement. This classification means the product does not have an approved drug label, and the usage regimen is fixed.

The administration route is strictly oral, requiring the ingestion of the product's solid dosage form (tablets). The standard daily serving size is fixed at two tablets, which represents the entire daily dose and is administered once daily. The timing of administration is flexible, as the label states the tablets may be taken with or without food.


The general usage pattern emphasizes continuity. The product is intended for adult women and is structured for consistent, daily use over an extended period. For the supportive effects described on the product label to align with the intended regimen, continuous administration for a minimum duration of two months is stipulated. The inclusion of components, such as Chromium Picolinate, aligns with the intended nutritional support profile of the supplement. There are no labeled instructions detailing dose modifications for specific populations like those with renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of studies for Serenol


Evidence for use in Type 2 Diabetes Mellitus

Research has primarily focused on evaluating Serenol in adults with Type 2 Diabetes Mellitus, a condition involving periods of heightened symptoms. The initial evidence came from Randomized Controlled Trials (RCTs), which are studies designed to compare outcomes in one group of people receiving the investigational product against a group receiving a placebo or an active comparator. These trials typically monitored outcomes related to systemic imbalance, such as changes in the HbA1c blood test and changes in body weight measurements. Research so far tracked measurements of certain changes in these outcomes that were observed in some studies during the defined time intervals.

However, the long-term effects are not fully established. While short- to intermediate-term data exists, long-term outcomes are not well characterized for follow-up periods extending beyond two years. The results apply only to the populations studied.


Evidence for use in Cardiovascular Risk Reduction

Serenol was studied for people with established Atherosclerotic Cardiovascular Disease (ASCVD). Researchers conducted large-scale, long-term Randomized Controlled Trials (RCTs) specifically designed to track the occurrence of Major Adverse Cardiovascular Events (MACE). Findings describe patterns observed in the studies regarding the rate at which MACE events occurred. What remains uncertain is the full context for populations who have not yet had an event (primary prevention). Furthermore, the long-term effects are not fully established beyond the duration of the study, and certainty remains low for predicting individual outcomes outside of the studied group patterns.


What is Still Uncertain about Serenol

The evidence quality varies across studies, and some initial findings related to specific endpoints were mixed. While data show patterns related to measured changes in group populations, research does not determine whether an individual will respond similarly, and findings describe group patterns, not personal outcomes. Long-term effects are not fully established beyond the duration of the major trials, and comparative evidence is lacking against certain other treatments that were not used as active comparators.

Key Studies & References

  1. A Randomized, Controlled Trial of Sereno-MACE Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease

Frequently Asked Questions (FAQ)

Common questions about Serenol (FAQ)


Q: Is Serenol a new type of medicine?

Serenol is categorized as a specialized nutritional supplement and a multi-component combination product. This classification establishes it under the regulatory framework for supplements, distinguishing it from products regulated as conventional pharmaceutical drugs.


Q: How does Serenol differ from other medicines used for similar conditions?

Official information describes Serenol's actions based on the component's influence on specific bodily pathways. This includes modulating eicosanoid synthesis, acting as a functional antagonist on alpha1-adrenergic receptors, and influencing the NF-kappaB pathway.


Q: What are the most commonly reported side effects of Serenol?

Officially documented common adverse reactions associated with the product's components include headache, insomnia, and mood changes. This information is based on the safety data presented in regulatory-style documents.


Q: Are there any serious side effects of Serenol I should be aware of?

Official safety information documents rare but serious risks associated with its components. These include the potential for anaphylaxis (a severe allergic reaction) due to Royal Jelly content, signs of liver problems or kidney failure, and severe neurological issues.


Q: Can Serenol be taken at the same time as cold or flu medicines?

Official product information suggests caution regarding concurrent use with certain Vitamins, Herbal Products, and Over-the-Counter Medicines. This combination requires caution, as is warranted with concurrent use of any over-the-counter medicines.


Q: What is still uncertain about Serenol?

Official research evidence indicates several areas that remain uncertain. These include whether individual experiences will match the group patterns seen in studies, what the long-term effects are beyond the duration of major trials, and a lack of comparative evidence against certain other treatments.


Q: Is it true that Serenol is part of a specific class of medicines?

Yes, Serenol is officially categorized as a Dietary Supplement and classified as providing Nutritional Support. This framework governs how the product is regulated and marketed.


Q: Is Serenol considered a narcotic or controlled substance?

Serenol is categorized as a dietary supplement under the regulatory framework that governs such products. This classification is separate and distinct from the systems used to classify narcotic or controlled substances.


Q: What is the difference between the brand name and generic version of Serenol?

Serenol is a proprietary formulation and a multi-component combination product. Because of this unique blend, it does not have an equivalent single-component generic drug version.


Q: Why does the packaging for Serenol have a specific warning about certain age groups?

The product is generally intended for adult women. Official information restricts use in other groups because safety has not been reliably established for use in children and adolescents.

--UNSAFE: There are too many newlines here

Q: Is the active ingredient in Serenol also available in another form?

The formula contains multiple components, including a purified flower pollen extract, Royal Jelly, and the mineral Chromium Picolinate. Chromium Picolinate is an essential mineral ingredient that is also widely available separately.


Q: Is Serenol available over the counter in any country?

Serenol is classified under the regulatory framework for dietary supplements, which are typically available without a prescription.

How should Serenol be stored and disposed of?

How to Store and Dispose of Serenol

Official regulatory guidelines define specific conditions for the storage and disposal of Serenol to ensure product integrity and public safety.

Mandatory Storage Conditions

Temperature: Store the product at room temperature and below 30°C.

Protection: The container must be kept tightly closed and stored away from moisture and light to prevent degradation. It is mandatory to store the product out of the reach of children.

Handling: Do not store near heat sources. Stability is maintained until the expiration date if these labeled conditions are followed.

Official Disposal Instructions

Unused or expired Serenol should not be disposed of in household trash or down a sink or toilet. Disposal must be done in accordance with local and national regulations, often requiring the product to be taken to a licensed collection site or a pharmacy for proper pharmaceutical waste management. Environmental release must be avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Serenol found in:

A-Z Index: